Clinical Trial Update: AMD3100 Plus Mitoxantrone, Etoposide and Cytarabine in Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study of AMD3100 (plerixafor) plus mitoxantrone, etoposide, and cytarabine in adults with acute myeloid leukemia; the trial completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Etoposide (Etoposide)
• Mitoxantrone (mitoxantrone)
• Plerixafor (AMD3100) (Plerixafor)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Leukemia, Myeloid, Acute | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-09-22